A potential $4 billion market, an unmet clinical need in the field of heart valve disease, 1.8 million high-risk patients with mitral regurgitation who cannot be operated on, and the impatience and appetite of industrial players for a new innovative technology. This seed round aims at completing the product concept freeze.Go on website
Osimis technology helps clinical teams and medtech professionals optimize the management of their me...
Protect your property and your loved ones with an all-in-one insurance solution!
The CADISS® System is a novel line of medical devices for the selective dissection of pathological t...
iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and develo...
Twistiti developed a unique concept that replaces numbers on the watch, which are usually difficult...
Eat organic, local and seasonal from the farm to your home in 1 click on efarmz.be
CERHUM's main expertise is additive manufacturing (3D printing) on demand, but also the supply of ra...
Elysia-raytest group provides Quality Control Solutions to the pharmaceutical, agrochemical and nucl...
Relieving pain and anxiety in patients through virtual reality, without medication
To rent, for a few hours, exceptional places for various events, this is the challenge that two peop...